APG Asset Management US Inc. Has $1.17 Million Holdings in CVS Health Co. (NYSE:CVS)

APG Asset Management US Inc. increased its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 45.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 25,996 shares of the pharmacy operator's stock after acquiring an additional 8,163 shares during the quarter. APG Asset Management US Inc.'s holdings in CVS Health were worth $1,167,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Arete Wealth Advisors LLC bought a new position in CVS Health during the 3rd quarter valued at $1,369,000. Morse Asset Management Inc acquired a new position in CVS Health in the third quarter worth $409,000. Wellington Management Group LLP increased its stake in CVS Health by 6.2% during the third quarter. Wellington Management Group LLP now owns 224,248 shares of the pharmacy operator's stock valued at $14,101,000 after purchasing an additional 13,120 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of CVS Health by 1.8% during the third quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator's stock worth $1,651,997,000 after purchasing an additional 461,569 shares during the period. Finally, Coldstream Capital Management Inc. boosted its stake in CVS Health by 27.8% during the 3rd quarter. Coldstream Capital Management Inc. now owns 17,400 shares of the pharmacy operator's stock valued at $1,084,000 after purchasing an additional 3,788 shares during the period. Hedge funds and other institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CVS. Truist Financial boosted their price objective on CVS Health from $76.00 to $82.00 and gave the stock a "buy" rating in a research report on Friday. Leerink Partnrs raised CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 12th. Edward Jones raised shares of CVS Health from a "hold" rating to a "buy" rating in a report on Thursday, January 30th. Robert W. Baird raised their target price on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research note on Tuesday. Finally, JPMorgan Chase & Co. boosted their price target on shares of CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 18th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $71.83.

Insiders Place Their Bets

In other news, SVP James David Clark sold 7,513 shares of the business's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael F. Mahoney acquired 30,000 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.24% of the company's stock.

CVS Health Stock Down 0.2 %

Shares of NYSE CVS traded down $0.13 during mid-day trading on Tuesday, reaching $69.07. The company had a trading volume of 2,225,311 shares, compared to its average volume of 11,731,091. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $71.66. The stock's 50 day moving average is $65.37 and its 200-day moving average is $58.58. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The stock has a market capitalization of $87.08 billion, a PE ratio of 18.87, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, equities analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.85%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health's payout ratio is 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.